Interpace Biosciences, Inc. Financial Ratios — IDXG Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-10.02	-26.61	-6.19	-17.38	-12.37	-15.22	-25.62	-29.99	-64.69	-54.41	-35.53	-80.72	13.43	48.03	101.07
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1.28	-3.2	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-40.33	- -
Gross Margin (%)	20.64	21.17	16.04	13.98	26.74	49.25	53.71	53.43	34.4	33.1	56.78	57.26	62.58	63.77	62.31
EBITDA Margin (%)	0.78	0.81	-0.01	-905.63	-273.88	-79.91	-51.61	-33.39	-80.19	-57.03	-1.18	-1.06	13.9	18.87	12.67
Operating Margin (%)	-1.15	-0.8	-0.98	-1,067.84	-327.21	-114.17	-74.83	-50.74	-98.87	-74.01	-17.4	-12.06	9.9	17.28	10.55
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	95.18	60.16	49.09
Pretax Margin (%)	-3	-19.91	-1.02	-1,254.82	-468.68	-65.51	-82.61	-58.01	-110.16	-80.71	-23.38	-18.33	5.7	14.81	9.74
Profit Margin (%)	-7.57	-20.12	-3.12	-1,090.43	-120.4	-63.68	-76.84	-58.02	-110.4	-81.64	-45.12	-68.97	4.88	14.28	63.46
Net Income to Common Margin (%)	-7.57	-20.12	-3.12	-1,090.43	-120.4	-63.68	-76.84	-58.02	-112.18	-81.64	-45.12	-68.97	4.88	13.29	63.46
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.75	0.06	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	1.58	- -	- -	- -	- -	-7.16	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	27	8	8	- -	- -	7	5	11	16	11	6	1
ST Debt	- -	- -	- -	- -	1	- -	- -	- -	2	1	1	3	5	5	- -
LT Debt	- -	- -	- -	27	7	8	- -	- -	6	4	10	13	6	1	1
Total Debt/EBITDA	- -	- -	- -	-2.03	-0.33	-0.76	- -	- -	-0.37	-0.26	-27.5	-47.61	2.01	0.66	0.24
Net Debt/EBITDA	-52.18	-51.5	3,803.25	-0.3	- -	-0.7	1.85	0.83	-0.03	0.15	-17.36	-26.14	1.05	0.32	-0.51
Total Debt/EBIT	- -	- -	- -	-1.73	-0.27	-0.53	- -	- -	-0.3	-0.2	-1.86	-4.19	2.82	0.72	0.29
Net Debt/EBIT	35.49	52.31	31.76	-0.26	- -	-0.49	1.28	0.55	-0.03	0.12	-1.17	-2.3	1.47	0.35	-0.61
EBITDA to Interest Expense	- -	- -	- -	-22.17	-6.97	-4.88	-18.95	-22.08	-44.14	-33.65	-0.38	-0.34	5.52	13.44	29.2
EBITDA-CapEx/Interest Expense	- -	- -	- -	-41.03	-7.07	-4.88	-19.02	-23.44	-44.44	-36.52	-0.72	-0.65	5.05	12.11	27.08
EBIT to Interest Expense	- -	- -	- -	-26.15	-8.33	-6.97	-27.47	-33.57	-54.42	-43.67	-5.54	-3.81	3.93	12.3	24.31
Interest Expense	- -	- -	- -	1	4	2	- -	- -	- -	1	1	1	1	1	- -
Common Equity/Total Assets	-47.25	-100.83	-121.13	-86.04	-164.27	-286.18	-245.39	-509.83	-359.47	-463.46	-589.84	-1,555.87	-1,842.61	-1,588.52	-621.78
Long-Term Debt/Equity (%)	- -	- -	- -	134.95	55.48	121.08	- -	- -	25.77	- -	- -	- -	- -	- -	3.36
Long-Term Debt/Capital (%)	- -	- -	- -	-37.41	-7.03	-7.08	- -	- -	-3.68	-2.21	-5.88	-5.6	-2.48	-0.52	-0.36
Long-Term Debt/Total Assets (%)	- -	- -	- -	23.43	10.68	18.93	- -	- -	10.85	7.75	25.92	81.44	43.57	8	2.22
Total Debt/Equity (%)	- -	- -	- -	134.95	64.4	121.08	- -	- -	32.71	-16.31	-25.28	-25.51	-20.15	-264.14	5.29
Total Debt/Capital (%)	- -	- -	- -	-37.41	-8.17	-7.08	- -	- -	-4.67	-2.96	-6.33	-6.92	-4.86	-2.56	-0.57
Total Debt/Total Assets (%)	- -	- -	- -	23.43	12.4	18.93	- -	- -	13.77	10.39	27.91	100.7	85.33	39.59	3.5
Net Debt to Equity	-108.09	-148.14	-140.52	20.09	0.67	111.87	-38.12	-39.29	3.13	9.53	-15.96	-14.01	-10.52	-127.6	-11.2
Net Debt/Capital (%)	54.56	40.02	35.3	-4.23	-0.08	-6.51	10.36	3.68	-0.44	1.7	-3.93	-3.72	-2.5	-1.23	1.18
EBITDA	1	1	- -	-13	-26	-10	-8	-7	-19	-18	- -	- -	6	9	5
EBITDA-CapEx	1	- -	-2	-25	-26	-10	-8	-8	-20	-20	-1	-1	5	8	5
Operating Income (Loss)	-2	-1	-1	-16	-31	-15	-12	-11	-24	-24	-6	-4	4	8	4

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.4	1.45	1.46	0.69	0.36	0.04	1.88	0.7	0.13	0.15	0.17	0.34	0.31	0.14	0.49
Current Ratio	1.74	1.97	2	1.34	0.82	0.26	2.45	2.04	0.95	0.77	0.78	0.85	0.91	1.11	1.94
Quick Ratio	1.66	1.8	1.77	0.86	0.52	0.19	2.3	1.79	0.73	0.59	0.47	0.69	0.75	0.94	1.6
CFO/Avg Current Liab	0.04	-0.25	-0.1	-0.5	-0.7	-0.38	-1.25	-1.03	-1.46	-0.79	-0.51	-0.51	0.29	0.42	0.74
Common Equity/Total Assets	-47.25	-100.83	-121.13	-86.04	-164.27	-286.18	-245.39	-509.83	-359.47	-463.46	-589.84	-1,555.87	-1,842.61	-1,588.52	-621.78
Long-Term Debt/Equity (%)	- -	- -	- -	134.95	55.48	121.08	- -	- -	25.77	- -	- -	- -	- -	- -	3.36
Long-Term Debt/Capital (%)	- -	- -	- -	-37.41	-7.03	-7.08	- -	- -	-3.68	-2.21	-5.88	-5.6	-2.48	-0.52	-0.36
Long-Term Debt/Total Assets (%)	- -	- -	- -	23.43	10.68	18.93	- -	- -	10.85	7.75	25.92	81.44	43.57	8	2.22
Total Debt/Equity (%)	- -	- -	- -	134.95	64.4	121.08	- -	- -	32.71	-16.31	-25.28	-25.51	-20.15	-264.14	5.29
Total Debt/Capital (%)	- -	- -	- -	-37.41	-8.17	-7.08	- -	- -	-4.67	-2.96	-6.33	-6.92	-4.86	-2.56	-0.57
Total Debt/Total Assets (%)	- -	- -	- -	23.43	12.4	18.93	- -	- -	13.77	10.39	27.91	100.7	85.33	39.59	3.5
CFO/Total Liabilities	3.69	-24.02	-9.6	-17.1	-36.29	-21.58	-111.17	-55.31	-63.51	-18.7	-10.78	-9.73	5.52	27.31	50.81
CFO/CapEx	5.79	-9.25	-1.93	-1.44	-56.21	- -	-526.31	-19.32	-144.71	-8.88	-24.63	-23.89	8.06	5.3	16.38
Altman's Z-Score	2.38	2.28	2.06	-3.16	-10.38	-40.09	-8.75	-11.32	-11.2	-13.36	-8.26	-21.93	-21.84	-16.78	-6.72

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	15.2	12.49	23.28	0.51	2.84	5.22	5.63	3.39	2.44	3.53	5.22	6.56	7.92	6.89	5.46
Days Sales Outstanding	24.01	29.22	15.68	710.56	128.52	69.95	64.82	107.69	149.35	103.46	69.99	55.62	46.09	52.98	66.88
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	17.41	11.18	9.95	13.28	12.22	13.95	12.56
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	20.96	32.65	36.68	27.48	29.86	26.17	29.07
Accounts Payable Turnover	33.71	26.58	44.03	0.58	3.71	3.42	5.42	14.06	6.14	4.75	4.45	11.56	11.55	10.61	10.98
Accounts Payable Turnover Days	10.83	13.73	8.29	627.81	98.3	106.79	67.39	25.95	59.43	76.83	82.07	31.59	31.6	34.42	33.25
Cash Conversion Cycle	13.18	15.49	7.39	82.75	30.21	-36.84	-2.57	81.74	110.89	59.27	24.6	51.52	44.35	44.73	62.7
Inventory to Cash Days	24.01	29.22	15.68	710.56	128.52	69.95	64.82	107.69	128.39	70.81	33.31	28.14	16.23	26.81	37.82
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	2	2	1	1	1	1	1
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	2	2	1	1	1	1	1
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	93	111	71	27	7	8	16	23	19	13	31	4	5	12	5
- Cash & Cash Equivalents	64	53	46	23	8	1	15	6	2	3	3	5	3	1	3
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	26	47	47	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	27	8	8	- -	- -	7	5	11	16	11	6	1
Enterprise Value	28	58	25	31	7	15	1	16	50	61	85	16	12	16	4
Total Capital	-54	-79	-84	-73	-103	-112	-132	-159	-152	-160	-169	-233	-230	-229	-209
Total Debt/Capital (%)	- -	- -	- -	-37.41	-8.17	-7.08	- -	- -	-4.67	-2.96	-6.33	-6.92	-4.86	-2.56	-0.57
Total Debt / EV	- -	- -	- -	0.89	1.17	0.52	- -	- -	0.14	0.08	0.13	1.03	0.91	0.36	0.29
EV/Sales	0.18	0.46	0.17	20.77	0.76	1.17	0.06	0.75	2.05	1.89	2.58	0.49	0.31	0.35	0.11
EV/EBITDA	22.9	56.56	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.22	1.83	0.84
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.12	2	1.01
EV/Cash Flow to Firm	14.23	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.58	3.06	0.59
EV/Free Cash Flow to Firm	12.13	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.35	2.63	0.56
Diluted Market Cap	93	111	71	27	7	8	16	23	19	13	31	4	5	42	34
Diluted Enterprise Value	28	58	25	31	7	15	1	16	50	61	85	16	12	47	33
EV per Share	195.57	397.47	170.21	205.41	46.38	84.23	0.56	5.84	13.26	15.18	20.67	3.7	2.86	3.7	0.93
TTM Sales	157	127	147	1	9	13	16	22	24	32	33	32	40	47	39
TTM EBITDA	1	1	- -	-13	-26	-10	-8	-7	-19	-18	- -	- -	6	9	5
TTM Operating Income	-2	-1	-1	-16	-31	-15	-12	-11	-24	-24	-6	-4	4	8	4
TTM Cash Flow to Firm	2	-10	-4	-16	-17	-6	-15	-8	-19	-13	-8	-7	5	5	7
TTM Free Cash Flow to Firm	2	-9	-2	-5	-17	-6	-15	-8	-18	-12	-7	-6	5	6	7

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	39.82	-12.08	-41.79	-5.31	-0.37	-1.05	-1.06	-2.74	-0.99	-1.02	-3.69	-0.6	1.11	7.69	5.51
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.12	2	1.01
Enterprise Value	28	58	25	31	7	15	1	16	50	61	85	16	12	16	4
Low Price	527	584	382	134	42.2	7	7.2	7.63	3.81	2.57	2.98	0.51	0.62	0.82	0.44
EV/Sales	0.18	0.46	0.17	20.77	0.76	1.17	0.06	0.75	2.05	1.89	2.58	0.49	0.31	0.35	0.11
EV/EBITDA	22.9	56.56	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.22	1.83	0.84
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.39	1.9	0.22
Price/Earnings Average	-9.15	-4.12	-17.29	-3.45	-2.08	-0.68	-2.55	-2.39	-1.07	-0.77	-2.11	-0.64	2.82	1.19	0.18
Price/Earnings High	-13.76	-5.07	-26.6	-5.79	-3.74	-4.32	-18.39	-3.95	-1.54	-1.68	-2.91	-1.64	7.82	2.49	0.49
Price/Earnings Low	-6.39	-3.34	-12.32	-1.24	-0.58	-0.15	-0.93	-1.69	-0.53	-0.39	-0.82	-0.1	1.37	0.58	0.08
Price/Book Value	-1.73	-1.4	-0.85	-0.27	-0.06	-0.07	-0.12	-0.14	-0.1	-0.06	-0.14	-0.02	-0.02	-0.05	-0.03
Price/Book Value Average	-2.04	-1.33	-0.94	-0.56	-0.21	-0.05	-0.24	-0.19	-0.16	-0.1	-0.14	-0.06	-0.02	-0.03	-0.02
Price/Book Value High	-3.06	-1.64	-1.45	-0.93	-0.38	-0.3	-1.71	-0.32	-0.23	-0.21	-0.19	-0.14	-0.06	-0.07	-0.06
Price/Book Value Low	-1.42	-1.08	-0.67	-0.2	-0.06	-0.01	-0.09	-0.14	-0.08	-0.05	-0.05	-0.01	-0.01	-0.02	-0.01
Price/Tangible Book Value	2.78	3.35	2.18	-0.62	-0.24	-0.27	2.38	7.75	-0.65	-0.13	-0.34	-0.07	-0.08	-5.34	0.24
Price/Tangible Book Value Average	3.27	3.18	2.43	-1.3	-0.77	-0.19	4.6	10.45	-1.01	-0.21	-0.35	-0.22	-0.1	-3.34	0.2
Price/Tangible Book Value High	4.92	3.91	3.74	-2.18	-1.39	-1.21	33.21	17.23	-1.45	-0.46	-0.48	-0.56	-0.28	-7	0.53
Price/Tangible Book Value Low	2.28	2.57	1.73	-0.47	-0.21	-0.04	1.68	7.39	-0.5	-0.11	-0.14	-0.03	-0.05	-1.62	0.09
Price/Sales	0.59	0.87	0.48	18.1	0.76	0.61	1.01	1.03	0.77	0.39	0.93	0.14	0.12	0.25	0.14
Price/Sales Average	0.69	0.83	0.54	37.59	2.5	0.43	1.96	1.39	1.2	0.63	0.95	0.44	0.14	0.16	0.11
Price/Sales High	1.04	1.02	0.83	63.18	4.5	2.75	14.13	2.29	1.73	1.37	1.31	1.13	0.38	0.33	0.31
Price/Sales Low	0.48	0.67	0.38	13.55	0.69	0.1	0.71	0.98	0.59	0.32	0.37	0.07	0.07	0.08	0.05
Price/Cash Flow	46.7	-10.78	-20.16	-1.63	-0.36	-1.05	-1.05	-2.6	-0.99	-0.91	-3.54	-0.57	1.23	2.55	0.93
Price/Cash Flow Average	54.93	-10.23	-22.47	-3.38	-1.19	-0.74	-2.04	-3.5	-1.53	-1.45	-3.62	-1.82	1.46	1.59	0.76
Price/Cash Flow High	82.57	-12.59	-34.57	-5.69	-2.14	-4.73	-14.72	-5.78	-2.2	-3.17	-4.98	-4.68	4.03	3.34	2.05
Price/Cash Flow Low	38.34	-8.28	-16.01	-1.22	-0.33	-0.17	-0.74	-2.48	-0.75	-0.74	-1.41	-0.28	0.71	0.77	0.34
Price/Free Cash Flow Average	46.84	-11.47	-46.58	-11.02	-1.21	-0.74	-2.04	-3.7	-1.54	-1.64	-3.77	-1.9	1.31	4.8	4.47
Price/Free Cash Flow High	70.4	-14.12	-71.68	-18.53	-2.18	-4.73	-14.75	-6.09	-2.22	-3.57	-5.2	-4.88	3.63	10.09	12.09
Price/Free Cash Flow Low	32.69	-9.28	-33.19	-3.97	-0.34	-0.17	-0.75	-2.61	-0.76	-0.84	-1.47	-0.29	0.64	2.34	1.98
EV/Sales Average	0.28	0.41	0.23	40.33	2.51	0.99	1	1.11	2.47	2.12	2.6	0.79	0.33	0.25	0.08
EV/Sales High	0.63	0.6	0.52	65.93	4.51	3.31	13.18	2.01	3	2.87	2.96	1.48	0.57	0.42	0.27
EV/Sales Low	0.07	0.26	0.07	16.29	0.7	0.66	- -	0.7	1.87	1.82	2.02	0.42	0.26	0.17	0.02
EV/EBITDA Average	36.25	51.17	-2,772.47	-4.45	-0.92	-1.24	-1.94	-3.33	-3.08	-3.72	-220.86	-74.7	2.37	1.33	0.63
EV/EBITDA High	80.74	74.86	-6,315.38	-7.28	-1.65	-4.14	-25.53	-6.03	-3.75	-5.02	-251.4	-139.77	4.13	2.25	2.17
EV/EBITDA Low	9.54	31.6	-881.98	-1.8	-0.26	-0.82	0.47	-2.11	-2.33	-3.19	-171.56	-39.72	1.86	0.9	0.13
EV/EBIT Average	-24.66	-51.98	-23.15	-3.78	-0.77	-0.87	-1.34	-2.19	-2.5	-2.87	-14.94	-6.58	3.33	1.45	0.76
EV/EBIT High	-54.91	-76.05	-52.74	-6.17	-1.38	-2.9	-17.61	-3.96	-3.04	-3.87	-17.01	-12.3	5.8	2.46	2.6
EV/EBIT Low	-6.49	-32.1	-7.37	-1.53	-0.21	-0.57	0.32	-1.39	-1.89	-2.46	-11.61	-3.5	2.62	0.99	0.16
Last Price	642	760	481	179	46.5	44	10.2	8	5	3.14	7.47	1.04	1.08	2.7	1.23
High Price	1,135	888	825	625	274	198	142.5	17.8	11.16	11	10.51	8.49	3.54	3.54	2.7
Enterprise Value Average	45	52	33	59	24	13	16	24	60	69	86	25	13	12	3
Enterprise Value High	100	77	76	97	43	43	209	44	73	93	98	47	23	20	11
Enterprise Value Low	12	32	11	24	7	9	-4	15	45	59	67	13	10	8	1

Shares Outstanding	- -	- -	- -	- -	- -	- -	3	3	4	4	4	4	4	4	4
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	2	3	4	4	4	4	4	16	28
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	2	3	4	4	4	4	4	4	4
Revenue per Share	1,089.27	870.07	995.61	9.89	60.93	72.05	10.08	7.78	6.47	8.04	8.01	7.51	9.27	10.7	8.75
EBITDA per Share	8.54	7.03	-0.08	-89.58	-166.87	-57.58	-5.2	-2.6	-5.18	-4.59	-0.09	-0.08	1.29	2.02	1.11
Operating Income per Share	-12.56	-6.92	-9.76	-105.63	-199.37	-82.26	-7.54	-3.95	-6.39	-5.95	-1.39	-0.91	0.92	1.85	0.92
Basic EPS, GAAP	-82.51	-175.02	-31.02	-107.87	-73.36	-45.88	-7.75	-4.51	-7.25	-6.57	-3.61	-5.18	0.45	1.42	5.55
Basic EPS from Cont Ops	-26.16	-174.62	-11.39	-90.37	-200.71	-46.31	-8.08	-4.52	-7.11	-6.5	-1.7	-1.38	0.52	1.58	5.65
Diluted EPS, GAAP	-82.51	-175.02	-31.02	-107.87	-73.36	-45.88	-7.75	-4.51	-7.25	-6.57	-3.61	-5.18	0.45	0.4	0.89
Diluted EPS from Cont Ops	-26.16	-174.62	-11.39	-90.37	-200.71	-46.31	-8.08	-4.52	-7.11	-6.5	-1.7	-1.38	0.52	0.44	0.9
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	13.75	-70.52	-23.86	-109.91	-128.18	-41.89	-9.68	-3.08	-5.06	-3.47	-2.11	-1.82	0.88	1.06	1.32
Free Cash Flow per Basic Share	11.37	-78.15	-36.21	-186.09	-130.46	-41.89	-9.7	-3.24	-5.1	-3.86	-2.19	-1.89	0.77	0.86	1.24
Cash & Equivalents per Share	446.43	362.53	310.79	155.82	54.37	3.31	9.64	2.16	0.62	0.69	0.65	1.14	0.81	0.33	0.57
Book Value per Share	-371	-542.32	-568.42	-669.29	-718.56	-658.38	-83.42	-56.36	-49.46	-52.55	-54.81	-58.66	-55.98	-53.56	-47.56
Tangible Book Value per Share	230.65	226.99	220.68	-286.74	-196.73	-164.25	4.29	1.03	-7.68	-23.68	-22.03	-15.09	-12.87	-0.51	5.05

Interpace Biosciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)